Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Every word you type has to appear somewhere in the question, and the closest matches are ranked first. Each row links to its question's own page, which gathers every review that asked it, however worded; see the questions asked by more than one review.

Population

Intervention or exposure

Comparison

Outcome

Any field or review title

Field or topic

Source

Review versions

15,213 questions in 2,394 reviews

current versions

No studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Question	Effect	Evidence	Status / GRADE
Intermittent oral diazepam vs intermittent oral clobazam Recurrent seizure at 18 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral diazepam vs intermittent oral clobazam Recurrent seizure at 24 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral diazepam vs intermittent oral clobazam Recurrent seizure at 36 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral diazepam vs intermittent oral clobazam Recurrent seizure at 48 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral diazepam vs intermittent oral clobazam Recurrent seizure at 60 months or greater · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 12 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 18 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 24 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 36 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 48 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral melatonin vs intermittent oral diazepam Recurrent seizures at 60 months or greater · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Intermittent oral levetiracetam vs placebo (any antipyretics) Recurrent seizures at 6 months · children with febrile seizures Prophylactic drug management for febrile seizures in children (2021) · Cochrane	no estimate extracted	NR	No studies
Ethosuximide vs lamotrigine 80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Ethosuximide vs lamotrigine 50% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Ethosuximide vs lamotrigine Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Ethosuximide vs valproate Normalisation of the EEG ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Lamotrigine vs valproate 80% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Lamotrigine vs valproate 50% or greater reduction in seizure frequency ‐ not reported · absence seizures in children and adolescents Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents (2021) · Cochrane	no estimate extracted	NR	No studies
Cannabidiol (10 mg/kg and 20 mg/kg) plus ASMs vs placebo plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Felbamate plus ASMs vs placebo plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Felbamate plus ASMs vs placebo plus ASMs Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Lamotrigine plus ASMs vs placebo plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Lamotrigine plus ASMs vs placebo plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Cannabidiol (10 mg/kg and 20 mg/kg) plus ASMs vs placebo plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Rufinamide plus ASMs vs placebo plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Rufinamide plus ASMs vs placebo plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Rufinamide plus ASMs vs other ASM plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Rufinamide plus ASMs vs other ASM plus ASMs Number of participants with ≥ 75% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Rufinamide plus ASMs vs other ASM plus ASMs Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Cannabidiol (10 mg/kg and 20 mg/kg) plus ASMs vs placebo plus ASMs Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Topiramate plus ASMs vs placebo plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Topiramate plus ASMs vs placebo plus ASMs Number of participants with ≥ 50% reduction in all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Cinromide plus ASMs vs placebo plus ASMs Number of participants with adverse events leading to study discontinuation · Lennox‐Gastaut syndrome, any age1 Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Clobazam (low, medium and high doses) plus ASMs vs placebo plus ASMs Number of participants free from all seizures · Lennox‐Gastaut syndrome, any age Anti‐seizure medications for Lennox‐Gastaut syndrome (2021) · Cochrane	no estimate extracted	NR	No studies
Warfarin vs placebo or no treatment Stroke · people with heart failure in sinus rhythm Anticoagulation versus placebo for heart failure in sinus rhythm (2021) · Cochrane	no estimate extracted	NR	No studies
Summary of findings ‐ withdrawal of penicillin prophylaxis vs continuation Compliance to treatment · children with SCD who have been receiving prophylactic penicillin for at least two years Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease (2021) · Cochrane	no estimate extracted	NR	No studies
Summary of findings ‐ initiation of penicillin prophylaxis vs placebo Antibiotic‐resistant organisms isolated · children with SCD Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease (2021) · Cochrane	no estimate extracted	NR	No studies
Summary of findings ‐ initiation of penicillin prophylaxis vs placebo Requirement of other courses of antibiotics · children with SCD Prophylactic antibiotics for preventing pneumococcal infection in children with sickle cell disease (2021) · Cochrane	no estimate extracted	NR	No studies
Visual interventions vs any control Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Prism adaptation training vs any control Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Prism adaptation training vs any control Adverse events · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Body awareness interventions vs any control Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Body awareness interventions vs any control Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Mental function interventions vs any control Primary outcome · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Mental function interventions vs any control Activities of daily living: effects persisting at least 1 month post intervention · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Mental function interventions vs any control Secondary outcomes · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Mental function interventions vs any control Neglect outcomes: effects persisting at least 1 month post intervention · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies
Mental function interventions vs any control Adverse events · spatial neglect or inattention following stroke and other adult‐acquired non‐progressive brain injury Non‐pharmacological interventions for spatial neglect or inattention following stroke and other… (2021) · Cochrane	no estimate extracted	NR	No studies